Trevi Therapeutics Unearned Premium on Insurance Contract (Quarterly) Insights

Trevi Therapeutics, Inc. (TRVI)

9.985 -0.96 (-8.73%) USD | NASDAQ | Jan 23, 16:00

10.19 +0.20 (+2.05%) After-Hours: 20:00

View Unearned Premium on Insurance Contract (Quarterly) for TRVI.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Unearned Premium on Insurance Contract (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Unearned Premium on Insurance Contract (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Unearned Premium on Insurance Contract (Quarterly) Benchmarks

Start Trial

CorMedix, Inc.	--
Arbutus Biopharma Corp.	--
Bristol Myers Squibb Co.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--